Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.160.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.428EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.374EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.63 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.377EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.298EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.30.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.76EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.385EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.384EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.123EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.143EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.46.6.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.112.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.360EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.347EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.195EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.321EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.379EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.78EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.231EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.190EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.120EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AM.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.249EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.505EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.406EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.115EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.190EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.552EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used